Vivos Inc. RDGL
0.04 USD 0.00 (-0.28%)
Nov 4, 2026, 12:34 PM EST
0.042 Day range 0.0423
0.0391 52-week range 0.1244
- YTD
- -38.61%
- 1 year
- -46.32%
- Market cap
- 20.91M
- EPS (ttm)
- -0.01
- YTD return
- -38.61%
- 1-year return
- -46.32%
- Volume
- 75.86K
- Avg volume
- 897.59K
- Open
- 0.0423
- Previous close
- 0.04242
- Day's range
- 0.042 – 0.0423
- 52-week range
- 0.0391 – 0.1244
2Y -0.0772 (-64.60%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Mar 18, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 6, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 4, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
Vivos Inc. Announces Expansion of IsoPet® Animal Cancer Division with Four New Veterinary Clinics Across the United States 
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders' Equity Standard 
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel 
Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test 
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives 
Vivos Therapeutics Announces Material Debt Reduction 
Vivos Inc. Announces Peer-Reviewed Publication Characterizing PrecisionGel™ Polymer Platform in Elsevier Journal of Drug Delivery Science and Technology 
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference 
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center 
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
Your note
Sign in to keep a note on RDGL — it syncs with the Stock Master app.